Zero - the End of Prostate Cancer
national nonprofit organization with the mission to end prostate cancer.
Based in VA
AI Overview
With $1.5M in lobbying spend across 32 quarterly filings, Zero - the End of Prostate Cancer is a significant lobbying presence. They deploy 39 individual lobbyists Their lobbying covers 5 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $160K |
| 2019 | $180K |
| 2020 | $200K |
| 2021 | $180K |
| 2022 | $200K |
| 2023 | $250K |
| 2024 | $200K |
| 2025 | $150K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Defense, Health Issues, Medicare/Medicaid, Budget/Appropriations, Veterans
DoD medical research
DoD & NIH prostate cancer research; prostate cancer screening treatment; ACA
Prostate cancer screening and treatment reimbursement
DoD Appropriations
DoD & NIH prostate cancer research; prostate cancer screening treatment; Affordable Care Act
DoD Appropriations and Center for Disease Control.
DoD & NIH prostate cancer research; prostate cancer screening, treatment and outreach
Department of Defense medical research
Showing 8 of 13 unique descriptions from filings.
Related Analysis
Related Investigations
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.